Acoustic Cardiographic Assessment of Heart Function and the Role of Phrenic Nerve Stimulation
NCT ID: NCT00541541
Last Updated: 2013-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
INTERVENTIONAL
2007-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acoustic Cardiographic Assessment of Heart Function in Comparison to Doppler-echocardiography
NCT00541801
Postoperative Atrial Fibrillation Suppression By Nerve Stimulation
NCT03533140
Risk of Pacing-induced Cardiomyopathy
NCT04269733
Mechanisms and Innovations in Cardiac Resynchronisation Therapy
NCT04221763
R Wave Sensing After VT Ablation
NCT03779165
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phrenic nerve stimulation
Patients receive a phrenic nerve stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with fast changing need of vasopressor therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inovise Medical
INDUSTRY
Luzerner Kantonsspital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Paul Erne
Prof. Paul Erne
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Erne, MD
Role: STUDY_CHAIR
Luzerner Kantonsspital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kantonsspital Luzern, Department of Cardiology
Lucerne, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Audicor-Pacing
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.